Fujian Aonong Biological Technology Group Incorporation Limited (603363.SS)
CNY 3.73
(3.9%)
CNY 3.73
(3.9%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.38 Billion CNY | -55.34% |
| 2022 | 3.1 Billion CNY | -30.5% |
| 2021 | 4.47 Billion CNY | 209.71% |
| 2020 | 1.44 Billion CNY | 10200.49% |
| 2019 | 14.02 Million CNY | -93.38% |
| 2018 | 212 Million CNY | -17.19% |
| 2017 | 256 Million CNY | 184.44% |
| 2016 | 90 Million CNY | 288.57% |
| 2015 | 23.16 Million CNY | 116.68% |
| 2014 | 10.68 Million CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 214.7 Million CNY | -81.35% |
| 2024 Q1 | 1.09 Billion CNY | -8.53% |
| 2024 Q3 | 122.45 Million CNY | -39.26% |
| 2023 Q4 | 1.38 Billion CNY | -51.09% |
| 2023 Q2 | 2.77 Billion CNY | -1.48% |
| 2023 Q1 | 2.81 Billion CNY | -9.57% |
| 2023 FY | 1.38 Billion CNY | -55.34% |
| 2023 Q3 | 2.83 Billion CNY | 2.5% |
| 2022 Q1 | 4.74 Billion CNY | 6.09% |
| 2022 FY | 3.1 Billion CNY | -30.5% |
| 2022 Q4 | 3.1 Billion CNY | -7.49% |
| 2022 Q2 | 4.41 Billion CNY | -7.02% |
| 2022 Q3 | 3.36 Billion CNY | -23.84% |
| 2021 Q2 | 4.13 Billion CNY | -0.87% |
| 2021 Q3 | 4.21 Billion CNY | 1.77% |
| 2021 Q4 | 4.47 Billion CNY | 6.19% |
| 2021 FY | 4.47 Billion CNY | 209.71% |
| 2021 Q1 | 4.17 Billion CNY | 189.09% |
| 2020 Q2 | 212 Million CNY | 1411.87% |
| 2020 Q4 | 1.44 Billion CNY | 22.98% |
| 2020 Q3 | 1.17 Billion CNY | 454.08% |
| 2020 FY | 1.44 Billion CNY | 10200.49% |
| 2020 Q1 | 14.02 Million CNY | -0.01% |
| 2019 Q4 | 14.02 Million CNY | -93.22% |
| 2019 FY | 14.02 Million CNY | -93.38% |
| 2019 Q2 | 207 Million CNY | -2.36% |
| 2019 Q3 | 207 Million CNY | 0.0% |
| 2019 Q1 | 212 Million CNY | 0.0% |
| 2018 Q2 | 253 Million CNY | -1.17% |
| 2018 FY | 212 Million CNY | -17.19% |
| 2018 Q4 | 212 Million CNY | -16.21% |
| 2018 Q3 | 253 Million CNY | 0.0% |
| 2018 Q1 | 256 Million CNY | 0.0% |
| 2017 FY | 256 Million CNY | 184.44% |
| 2017 Q1 | - CNY | -100.0% |
| 2017 Q2 | 102 Million CNY | 0.0% |
| 2017 Q3 | 117 Million CNY | 14.71% |
| 2017 Q4 | 256 Million CNY | 118.8% |
| 2016 Q4 | 90 Million CNY | 0.0% |
| 2016 FY | 90 Million CNY | 288.57% |
| 2015 FY | 23.16 Million CNY | 116.68% |
| 2014 FY | 10.68 Million CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |